Cargando…

Building clinical trial priorities at the University of Rwanda

After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda...

Descripción completa

Detalles Bibliográficos
Autores principales: Condo, Jeanine, Kateera, Brenda, Mutimura, Eugene, Birungi, Francine, Ndagijimana, Albert, Jansen, Stefan, Kamwesiga, Julius, Forrest, Jamie I, Mills, Edward J, Binagwaho, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289206/
https://www.ncbi.nlm.nih.gov/pubmed/25429819
http://dx.doi.org/10.1186/1745-6215-15-467
_version_ 1782352065770553344
author Condo, Jeanine
Kateera, Brenda
Mutimura, Eugene
Birungi, Francine
Ndagijimana, Albert
Jansen, Stefan
Kamwesiga, Julius
Forrest, Jamie I
Mills, Edward J
Binagwaho, Agnes
author_facet Condo, Jeanine
Kateera, Brenda
Mutimura, Eugene
Birungi, Francine
Ndagijimana, Albert
Jansen, Stefan
Kamwesiga, Julius
Forrest, Jamie I
Mills, Edward J
Binagwaho, Agnes
author_sort Condo, Jeanine
collection PubMed
description After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda in building an infrastructure for clinical trials. Through local examples, we discuss how a clinical trial infrastructure can be constructed by (1) building educational capacity; (2) encouraging the testing of relevant interventions using appropriate and cost-effective designs; and, (3) promoting ethical and regulatory standards. The future is bright for clinical research in Rwanda and with a renewed appetite for locally generated evidence it is necessary that we discuss the challenges and opportunities in drawing up a clinical trials agenda.
format Online
Article
Text
id pubmed-4289206
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42892062015-01-11 Building clinical trial priorities at the University of Rwanda Condo, Jeanine Kateera, Brenda Mutimura, Eugene Birungi, Francine Ndagijimana, Albert Jansen, Stefan Kamwesiga, Julius Forrest, Jamie I Mills, Edward J Binagwaho, Agnes Trials Commentary After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda in building an infrastructure for clinical trials. Through local examples, we discuss how a clinical trial infrastructure can be constructed by (1) building educational capacity; (2) encouraging the testing of relevant interventions using appropriate and cost-effective designs; and, (3) promoting ethical and regulatory standards. The future is bright for clinical research in Rwanda and with a renewed appetite for locally generated evidence it is necessary that we discuss the challenges and opportunities in drawing up a clinical trials agenda. BioMed Central 2014-11-27 /pmc/articles/PMC4289206/ /pubmed/25429819 http://dx.doi.org/10.1186/1745-6215-15-467 Text en © Condo et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Condo, Jeanine
Kateera, Brenda
Mutimura, Eugene
Birungi, Francine
Ndagijimana, Albert
Jansen, Stefan
Kamwesiga, Julius
Forrest, Jamie I
Mills, Edward J
Binagwaho, Agnes
Building clinical trial priorities at the University of Rwanda
title Building clinical trial priorities at the University of Rwanda
title_full Building clinical trial priorities at the University of Rwanda
title_fullStr Building clinical trial priorities at the University of Rwanda
title_full_unstemmed Building clinical trial priorities at the University of Rwanda
title_short Building clinical trial priorities at the University of Rwanda
title_sort building clinical trial priorities at the university of rwanda
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289206/
https://www.ncbi.nlm.nih.gov/pubmed/25429819
http://dx.doi.org/10.1186/1745-6215-15-467
work_keys_str_mv AT condojeanine buildingclinicaltrialprioritiesattheuniversityofrwanda
AT kateerabrenda buildingclinicaltrialprioritiesattheuniversityofrwanda
AT mutimuraeugene buildingclinicaltrialprioritiesattheuniversityofrwanda
AT birungifrancine buildingclinicaltrialprioritiesattheuniversityofrwanda
AT ndagijimanaalbert buildingclinicaltrialprioritiesattheuniversityofrwanda
AT jansenstefan buildingclinicaltrialprioritiesattheuniversityofrwanda
AT kamwesigajulius buildingclinicaltrialprioritiesattheuniversityofrwanda
AT forrestjamiei buildingclinicaltrialprioritiesattheuniversityofrwanda
AT millsedwardj buildingclinicaltrialprioritiesattheuniversityofrwanda
AT binagwahoagnes buildingclinicaltrialprioritiesattheuniversityofrwanda